The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
miRNA drugs can be divided into miRNA Antagonist and miRNA Mimics. miRNA Antagonist can bind to miRNA in the principle of complementary base pairing and degrade miRNA through RISC to inhibit the function of miRNA. miRNA Mimics have similar functions to miRNAs in the human body, and introducing them into pathological cells can restore their normal physiological functions.
The global miRNA Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for miRNA Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding miRNA Drug.
Report Scope
The miRNA Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global miRNA Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the miRNA Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mirna
EnGeneIC
Miragen Therapeutics
Regulus Therapeutics
Santaris Pharma
Segment by Type
miRNA Antagonist
miRNA Mimics
Segment by Application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of miRNA Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of miRNA Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
miRNA drugs can be divided into miRNA Antagonist and miRNA Mimics. miRNA Antagonist can bind to miRNA in the principle of complementary base pairing and degrade miRNA through RISC to inhibit the function of miRNA. miRNA Mimics have similar functions to miRNAs in the human body, and introducing them into pathological cells can restore their normal physiological functions.
The global miRNA Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for miRNA Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding miRNA Drug.
Report Scope
The miRNA Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global miRNA Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the miRNA Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mirna
EnGeneIC
Miragen Therapeutics
Regulus Therapeutics
Santaris Pharma
Segment by Type
miRNA Antagonist
miRNA Mimics
Segment by Application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of miRNA Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of miRNA Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 miRNA Drug Market Overview
1.1 Product Overview and Scope of miRNA Drug
1.2 miRNA Drug Segment by Type
1.2.1 Global miRNA Drug Market Value Comparison by Type (2024-2030)
1.2.2 miRNA Antagonist
1.2.3 miRNA Mimics
1.3 miRNA Drug Segment by Application
1.3.1 Global miRNA Drug Market Value by Application: (2024-2030)
1.3.2 Single Gene Rare Disease
1.3.3 Protein Deposition Disease
1.3.4 Chronic Liver Disease
1.3.5 Others
1.4 Global miRNA Drug Market Size Estimates and Forecasts
1.4.1 Global miRNA Drug Revenue 2019-2030
1.4.2 Global miRNA Drug Sales 2019-2030
1.4.3 Global miRNA Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 miRNA Drug Market Competition by Manufacturers
2.1 Global miRNA Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global miRNA Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global miRNA Drug Average Price by Manufacturers (2019-2024)
2.4 Global miRNA Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of miRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of miRNA Drug, Product Type & Application
2.7 miRNA Drug Market Competitive Situation and Trends
2.7.1 miRNA Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest miRNA Drug Players Market Share by Revenue
2.7.3 Global miRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 miRNA Drug Retrospective Market Scenario by Region
3.1 Global miRNA Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global miRNA Drug Global miRNA Drug Sales by Region: 2019-2030
3.2.1 Global miRNA Drug Sales by Region: 2019-2024
3.2.2 Global miRNA Drug Sales by Region: 2025-2030
3.3 Global miRNA Drug Global miRNA Drug Revenue by Region: 2019-2030
3.3.1 Global miRNA Drug Revenue by Region: 2019-2024
3.3.2 Global miRNA Drug Revenue by Region: 2025-2030
3.4 North America miRNA Drug Market Facts & Figures by Country
3.4.1 North America miRNA Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America miRNA Drug Sales by Country (2019-2030)
3.4.3 North America miRNA Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe miRNA Drug Market Facts & Figures by Country
3.5.1 Europe miRNA Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe miRNA Drug Sales by Country (2019-2030)
3.5.3 Europe miRNA Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific miRNA Drug Market Facts & Figures by Country
3.6.1 Asia Pacific miRNA Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific miRNA Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific miRNA Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America miRNA Drug Market Facts & Figures by Country
3.7.1 Latin America miRNA Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America miRNA Drug Sales by Country (2019-2030)
3.7.3 Latin America miRNA Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa miRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa miRNA Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa miRNA Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa miRNA Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global miRNA Drug Sales by Type (2019-2030)
4.1.1 Global miRNA Drug Sales by Type (2019-2024)
4.1.2 Global miRNA Drug Sales by Type (2025-2030)
4.1.3 Global miRNA Drug Sales Market Share by Type (2019-2030)
4.2 Global miRNA Drug Revenue by Type (2019-2030)
4.2.1 Global miRNA Drug Revenue by Type (2019-2024)
4.2.2 Global miRNA Drug Revenue by Type (2025-2030)
4.2.3 Global miRNA Drug Revenue Market Share by Type (2019-2030)
4.3 Global miRNA Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global miRNA Drug Sales by Application (2019-2030)
5.1.1 Global miRNA Drug Sales by Application (2019-2024)
5.1.2 Global miRNA Drug Sales by Application (2025-2030)
5.1.3 Global miRNA Drug Sales Market Share by Application (2019-2030)
5.2 Global miRNA Drug Revenue by Application (2019-2030)
5.2.1 Global miRNA Drug Revenue by Application (2019-2024)
5.2.2 Global miRNA Drug Revenue by Application (2025-2030)
5.2.3 Global miRNA Drug Revenue Market Share by Application (2019-2030)
5.3 Global miRNA Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mirna
6.1.1 Mirna Corporation Information
6.1.2 Mirna Description and Business Overview
6.1.3 Mirna miRNA Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mirna miRNA Drug Product Portfolio
6.1.5 Mirna Recent Developments/Updates
6.2 EnGeneIC
6.2.1 EnGeneIC Corporation Information
6.2.2 EnGeneIC Description and Business Overview
6.2.3 EnGeneIC miRNA Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 EnGeneIC miRNA Drug Product Portfolio
6.2.5 EnGeneIC Recent Developments/Updates
6.3 Miragen Therapeutics
6.3.1 Miragen Therapeutics Corporation Information
6.3.2 Miragen Therapeutics Description and Business Overview
6.3.3 Miragen Therapeutics miRNA Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Miragen Therapeutics miRNA Drug Product Portfolio
6.3.5 Miragen Therapeutics Recent Developments/Updates
6.4 Regulus Therapeutics
6.4.1 Regulus Therapeutics Corporation Information
6.4.2 Regulus Therapeutics Description and Business Overview
6.4.3 Regulus Therapeutics miRNA Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regulus Therapeutics miRNA Drug Product Portfolio
6.4.5 Regulus Therapeutics Recent Developments/Updates
6.5 Santaris Pharma
6.5.1 Santaris Pharma Corporation Information
6.5.2 Santaris Pharma Description and Business Overview
6.5.3 Santaris Pharma miRNA Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Santaris Pharma miRNA Drug Product Portfolio
6.5.5 Santaris Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 miRNA Drug Industry Chain Analysis
7.2 miRNA Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 miRNA Drug Production Mode & Process
7.4 miRNA Drug Sales and Marketing
7.4.1 miRNA Drug Sales Channels
7.4.2 miRNA Drug Distributors
7.5 miRNA Drug Customers
8 miRNA Drug Market Dynamics
8.1 miRNA Drug Industry Trends
8.2 miRNA Drug Market Drivers
8.3 miRNA Drug Market Challenges
8.4 miRNA Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global miRNA Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global miRNA Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global miRNA Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global miRNA Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global miRNA Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global miRNA Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global miRNA Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market miRNA Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of miRNA Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of miRNA Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of miRNA Drug, Product Type & Application
Table 12. Global Key Manufacturers of miRNA Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global miRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in miRNA Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global miRNA Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global miRNA Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global miRNA Drug Sales Market Share by Region (2019-2024)
Table 19. Global miRNA Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global miRNA Drug Sales Market Share by Region (2025-2030)
Table 21. Global miRNA Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global miRNA Drug Revenue Market Share by Region (2019-2024)
Table 23. Global miRNA Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global miRNA Drug Revenue Market Share by Region (2025-2030)
Table 25. North America miRNA Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America miRNA Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America miRNA Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America miRNA Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America miRNA Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe miRNA Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe miRNA Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe miRNA Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe miRNA Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe miRNA Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific miRNA Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific miRNA Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific miRNA Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific miRNA Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific miRNA Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America miRNA Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America miRNA Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America miRNA Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America miRNA Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America miRNA Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa miRNA Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa miRNA Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa miRNA Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa miRNA Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa miRNA Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global miRNA Drug Sales (K Units) by Type (2019-2024)
Table 51. Global miRNA Drug Sales (K Units) by Type (2025-2030)
Table 52. Global miRNA Drug Sales Market Share by Type (2019-2024)
Table 53. Global miRNA Drug Sales Market Share by Type (2025-2030)
Table 54. Global miRNA Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global miRNA Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global miRNA Drug Revenue Market Share by Type (2019-2024)
Table 57. Global miRNA Drug Revenue Market Share by Type (2025-2030)
Table 58. Global miRNA Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global miRNA Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global miRNA Drug Sales (K Units) by Application (2019-2024)
Table 61. Global miRNA Drug Sales (K Units) by Application (2025-2030)
Table 62. Global miRNA Drug Sales Market Share by Application (2019-2024)
Table 63. Global miRNA Drug Sales Market Share by Application (2025-2030)
Table 64. Global miRNA Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global miRNA Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global miRNA Drug Revenue Market Share by Application (2019-2024)
Table 67. Global miRNA Drug Revenue Market Share by Application (2025-2030)
Table 68. Global miRNA Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global miRNA Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Mirna Corporation Information
Table 71. Mirna Description and Business Overview
Table 72. Mirna miRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Mirna miRNA Drug Product
Table 74. Mirna Recent Developments/Updates
Table 75. EnGeneIC Corporation Information
Table 76. EnGeneIC Description and Business Overview
Table 77. EnGeneIC miRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. EnGeneIC miRNA Drug Product
Table 79. EnGeneIC Recent Developments/Updates
Table 80. Miragen Therapeutics Corporation Information
Table 81. Miragen Therapeutics Description and Business Overview
Table 82. Miragen Therapeutics miRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Miragen Therapeutics miRNA Drug Product
Table 84. Miragen Therapeutics Recent Developments/Updates
Table 85. Regulus Therapeutics Corporation Information
Table 86. Regulus Therapeutics Description and Business Overview
Table 87. Regulus Therapeutics miRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Regulus Therapeutics miRNA Drug Product
Table 89. Regulus Therapeutics Recent Developments/Updates
Table 90. Santaris Pharma Corporation Information
Table 91. Santaris Pharma Description and Business Overview
Table 92. Santaris Pharma miRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Santaris Pharma miRNA Drug Product
Table 94. Santaris Pharma Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. miRNA Drug Distributors List
Table 98. miRNA Drug Customers List
Table 99. miRNA Drug Market Trends
Table 100. miRNA Drug Market Drivers
Table 101. miRNA Drug Market Challenges
Table 102. miRNA Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of miRNA Drug
Figure 2. Global miRNA Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global miRNA Drug Market Share by Type in 2023 & 2030
Figure 4. miRNA Antagonist Product Picture
Figure 5. miRNA Mimics Product Picture
Figure 6. Global miRNA Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global miRNA Drug Market Share by Application in 2023 & 2030
Figure 8. Single Gene Rare Disease
Figure 9. Protein Deposition Disease
Figure 10. Chronic Liver Disease
Figure 11. Others
Figure 12. Global miRNA Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global miRNA Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global miRNA Drug Sales (2019-2030) & (K Units)
Figure 15. Global miRNA Drug Average Price (US$/Unit) & (2019-2030)
Figure 16. miRNA Drug Report Years Considered
Figure 17. miRNA Drug Sales Share by Manufacturers in 2023
Figure 18. Global miRNA Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest miRNA Drug Players: Market Share by Revenue in 2023
Figure 20. miRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global miRNA Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America miRNA Drug Sales Market Share by Country (2019-2030)
Figure 23. North America miRNA Drug Revenue Market Share by Country (2019-2030)
Figure 24. United States miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe miRNA Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe miRNA Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific miRNA Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific miRNA Drug Revenue Market Share by Region (2019-2030)
Figure 35. China miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America miRNA Drug Sales Market Share by Country (2019-2030)
Figure 43. Latin America miRNA Drug Revenue Market Share by Country (2019-2030)
Figure 44. Mexico miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa miRNA Drug Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa miRNA Drug Revenue Market Share by Country (2019-2030)
Figure 49. Turkey miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE miRNA Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of miRNA Drug by Type (2019-2030)
Figure 53. Global Revenue Market Share of miRNA Drug by Type (2019-2030)
Figure 54. Global miRNA Drug Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of miRNA Drug by Application (2019-2030)
Figure 56. Global Revenue Market Share of miRNA Drug by Application (2019-2030)
Figure 57. Global miRNA Drug Price (US$/Unit) by Application (2019-2030)
Figure 58. miRNA Drug Value Chain
Figure 59. miRNA Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
